• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Abivax SA - American Depositary Shares (NQ:ABVX)

    131.06 +0.82 (+0.63%)
    Streaming Delayed Price Updated: 9:36 AM EST, Feb 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 60,435
    Open 130.45
    Bid (Size) 131.00 (1,500)
    Ask (Size) 131.68 (300)
    Prev. Close 130.24
    Today's Range 129.90 - 131.18
    52wk Range 4.770 - 148.83
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Arcellx develops cell-based immunotherapies targeting cancer, with a lead candidate in early-stage trials for multiple myeloma. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Cogent Biosciences develops precision therapies for genetically defined diseases, with a pipeline targeting rare oncological conditions. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -2.0%
    -2.0%
    1 Month
    +10.3%
    +10.3%
    3 Month
    +6.6%
    +6.6%
    6 Month
    +76.1%
    +76.1%
    1 Year
    +1649.9%
    +1649.9%

    More News

    Read More
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    ABVX Soars Pre-Market On Reports Of $17.5 Billion Eli Lilly Takeover Interest ↗
    Via Stocktwits
    News headline image
    Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
    Via The Motley Fool
    News headline image
    Better Long-Term Buy: This Emerging Player or the Industry Leader? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗
    Via The Motley Fool
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Abivax Provides 2026 Corporate Outlook
    From Abivax
    Via GlobeNewswire
    News headline image
    Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Could This Potential Move Boost Eli Lilly's Prospects? ↗
    Via The Motley Fool
    News headline image
    The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade
    News headline image
    How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗
    Via Stocktwits
    News headline image
    Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics ETFs Stocks
    News headline image
    The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Why Abivax Stock Was on Fire Today ↗
    Via The Motley Fool
    News headline image
    Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Abivax to be Added to Nasdaq Biotechnology Index
    From Abivax
    Via GlobeNewswire
    News headline image
    The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
    From Abivax
    Via GlobeNewswire
    News headline image
    Abivax Presents Third Quarter 2025 Financial Results
    From Abivax
    Via GlobeNewswire
    News headline image
    2 Under-the-Radar Stocks That Have Soared This Year ↗
    Via The Motley Fool
    News headline image
    This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Abivax SA - American Depositary Shares publicly traded?
    Yes, Abivax SA - American Depositary Shares is publicly traded.
    What exchange does Abivax SA - American Depositary Shares trade on?
    Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Abivax SA - American Depositary Shares?
    The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
    What is the current price of Abivax SA - American Depositary Shares?
    The current price of Abivax SA - American Depositary Shares is 131.06
    When was Abivax SA - American Depositary Shares last traded?
    The last trade of Abivax SA - American Depositary Shares was at 02/20/26 09:36 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.